| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,172,196 | 792,158 | 814,650 | 1,210,434 | | Cost of Revenue | 955,503 | 723,321 | 855,277 | 1,251,345 | | | Gross Profit | 216,693 | 68,837 | (40,627) | (40,911) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,542 | 48,601 | 57,278 | 39,126 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 11,703 | 13,952 | 15,698 | 10,918 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 148,448 | 6,284 | (113,603) | (90,955) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,167 | (786) | 748 | 99 | | Earnings Before Interest And Taxes | 42,801 | 5,498 | (112,855) | (90,856) | | Interest Expense | (73,294) | 37,043 | 36,251 | 41,846 | | Income Before Tax | 116,095 | (31,545) | (149,106) | (132,702) | | Income Tax Expense | 47,365 | (15,024) | (59,332) | (50,029) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 71,460 | (16,521) | (89,774) | (82,673) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 71,460 | (16,521) | (89,774) | (82,673) | | Preferred Stock And Other Adjustments | (2,442) | 530 | 1,912 |
-
| | | Net Income Applicable To Common Shares | $69,018 | ($15,991) | ($87,862) | ($82,673) |
|
1.52% Nasdaq 0.00%
Income Statement
